Helices of ruthenium complexes involving pyridyl-azine ligands: synthesis, spectral and structural aspects

New cationic complexes [Ru(η⁵-C₅H₅)(EPh₃)(L)]BF₄ [L = pyridine-2-carbaldehyde azine (paa); E = P, 1; E = As, 2; E = Sb, 3] and κ¹ bonded dppm complexes [Ru(η⁵-C₅H₅)(κ¹-dppm)(L)]BF₄ [L = paa 4; L = p-phenylene-bis(picoline)aldimine (pbp) 5] containing both group V donor and pyridyl-azine ligand are reported. The complexes were fully characterized by analytical and spectral studies. ³¹P NMR spectral studies suggested coordination of dppm in the complexes 4 and 5 in κ¹-manner, which was further, confirmed by structural studies on the representative complex 4. Weak interaction studies revealed that inter- and intramolecular C-H?X (X = O, F, Cl, π) and π-π interactions in the complexes 1 and 4 lead to helical structures.     

Synthesis,biological activities studies of ruthenium(II) polypyridyl complexes

Four ruthenium(II) polypyridyl complexes were synthesized and characterized by elemental analysis, IR, ESI-MS and ¹H NMR. The in vitro cytotoxicities of the complexes against BEL-7402, HeLa, A549, HepG2 and MG-63 cancer cells were investigated by MTT methods, giving IC₅₀ values ranging from 6.9 to 43.5 μM. The complexes show their highest inhibitory effect on MG-63 cells, but no cytotoxic activities against HeLa cells. Cellular uptake experiments indicate that the complexes can enter the cytoplasm and accumulate in the cell nuclei. The complexes can induce apoptosis in MG-63 cells, enhance the levels of reactive oxygen species, and induce a decrease in mitochondrial membrane potential. The cell cycle distribution shows that the complexes induce cell cycle arrest at S phase in MG-63 cells. Additionally, these complexes can up-regulate the levels of Bad and Bid expression and down-regulate the expression of Bcl-2 and Bcl-x.     

Synthesis,structural characterization,antimicrobial, antioxidant and DNA binding studies of some novel homo‐binuclear Schiff base metal (II) complexes

A novel bi‐nucleating Schiff base ligand, 6,6′‐(((1E,1′E)‐thiophene‐2,5‐diylbis (methaneylylidene))bis (azaneylylidene))bis (3,4‐dimethylaniline), and five binuclear M (II) complexes were synthesized. The bi‐nucleating Schiff base ligand and its metal complexes were characterized using various physicochemical techniques, e.g. elemental analyses, spectroscopic methods, conductivity and magnetic moment measurements. The low molar conductance of the complexes in dimethylsulfoxide shows their non‐electrolytic nature. The antibacterial activities were screened against pathogenic bacteria (Staphylococcus aureus, Escherichia coli, Pseudomonas putida and Bacillus subtilis). The antifungal activity was screened against Aspergillus niger, Aspergillus flavus and Rhizoctonia bataicola. The antimicrobial activity data showed that the metal complexes are more potent than the parent Schiff base ligand against microorganisms. The antioxidant activities of the synthesized compounds were investigated through scavenging activity against 2,2‐diphenyl‐2‐picrylhydrazyl, superoxide anion, hydroxyl and 2,2′‐ azinobis (3‐ethylbenzothiazoline‐6‐sulfonic acid) radicals. The complexes have superior radical scavenging activity than the free ligand and the scavenging effects of the Cu (II) complex are stronger than those of the other complexes. DNA binding studies were performed using electronic spectroscopy, fluorometric competition studies and viscosity measurements. The data indicated that there is a marked enhancement in biocidal activity of the ligand under similar experimental conditions because of coordination with metal ions.     

Synthesis, structure and characterization of binuclear copper(Ⅱ) complexes

At room temperature, dibenzoyl peroxide undergoes oxidative addition reaction with metallic copper powder and pyridine N-oxide (triphenylphosphine oxide or 2,9-dimethyl-4,7-diphenyl-1,10-phenanthrolin) which affords the last products as binuclear copper(II) complexes, [Cu(C5H5NO)-(C6H5COO)2]2(1), [Cu(OPPh3)(C6H5COO)2]2(2) and [Cu(C6H5COO)(C26H2oN2)](3, C26H2oN2 is 2,9-dimethyl-4,7-diphenyl-1,10-phenanthrolin). The structure of the complexes were characterized by elemental analyses, IR spectra, TG-DTA and magnetic property. Crystals(1) are triclinic, space group P1,a=0.92617(36),b=1.06973(17), c=1.08813(29) nm, a=59.60(2)°, β=74.83(3)°,γ=72.80(2)°, V=0.880 nm3, Dc=1.520 g/cm3, Z=1, R=0.044, Rw=0.048, Mr=805.78, 3477 reflections with I > 3σ(I). Each copper(Ⅱ) ion is coordinated by two bridging bidentate benzoate ligands and one pyridine N-oxide or triphenylphosphine oxide to form dimeric binuclear molecules. The structure of the compound(1) shows a clear centre of symmetry.     

Protonation studies of reduced ruthenium(II) complexes with polypyridyl ligands

The pKa values associated with protonation of the one-electron reduced forms of series of [L'2Ru(II)L]2+ complexes [L' = bidentate polypyridyl ligand; L = bidentate polypyridyl ligand with additional uncoordinated N atoms in the aromatic ring system: e.g., dpp = 2,3-bis(2-pyridyl)pyrazine, bpz = 2,2'-bipyrazine] were assessed using pulse radiolysis techniques by the measurement of spectral variations as a function of pH. A linear correlation was observed between pKa and E (RuL'2L2+/+) for complexes in which the protonatable ligand was at the same time the site of reduction. In complexes where one or more of the nonprotonatable ligands (L') had very low pi* energy levels [e.g. (CF3)4bpy], reduction occurs on a nonprotonatable ligand and a dramatic decrease in the pKa values was observed for the reduced species. In complexes where the energies of the protonatable and nonprotonatable ligands were comparable, the protonation behavior was consistent with some orbital mixing/ delocalization of the electronic charge.     

Synthetic, spectral and solution studies on imidazolate-bridged copper(II)-copper(II) and copper(II)-zinc(II) complexes

Synthesis, spectral and solution studies on 2-ethyl imidazolate-bridged (2-EtIm) homo-binuclear copper(II)-copper(II) and hetero-binuclear copper(II)-zinc(II) homologue are described. Magnetic moment values of homo-binuclear complexes indicate that the imidazolate group can mediate antiferromagnetic interactions. Optical spectra of hetero-binuclear complex at varying pH values suggest that the imidazolate-bridged complex is stable over the pH-range 7.15–10.0.     

Synthesis and spectroscopic studies of novel mononuclear and binuclear ruthenium(III) complexes with bidentate and tridentate acyclic hydrazones

Nine novel acyclic hydrazone ligands, FINH?=?N-(furylidene)-N′-isonicotinoylhydrazine, FNH?=?N-(furylidene)-N′-nicotinoylhydrazine, PINH?=?N-(pyrienylidene)-N′-isonicotinoylhydrazine, PNH?=?N-(pyrienylidene)-N′-nicotinoylhydrazine, TINH?=?N-(thienylidene)-N′-isonicotinoylhydrazine, TNH?=?N-(thienylidene)-N′-nicotinoylhydrazine, FSH?=?N-(furylidene)-N′-salicyloylhydrazine, PSH?=?N-(pyrienylidene)-N′-salicyloylhydrazine and TSH?=?N-(thienylidene)-N′-salicyloylhydrazine, have been synthesized. Their corresponding mononuclear and binuclear ruthenium(III) complexes have been prepared by the reaction of the ligand with RuCl₃·3H₂O in 1?:?2 and 2?:?2 molar ratio and are characterized by elemental analyses, thermogravimetric analyses (TGA and DTG), IR, electronic, magnetic susceptibility and electrical conductance measurements. Electronic spectra and magnetic susceptibility measurements of the solid complexes (both mono- and binuclear) indicate an octahedral geometry around ruthenium(III). Particular emphasis is given to the binuclear complexes in which FSH, PSH and TSH behave as tridentate ligands and chloride bridges the Ru(III) ions. Conductance measurements show the mononuclear complexes are electrolytic and binuclear complexes are of non-electrolytic. The fungicidal activities of the ligands and metal complexes against Fusarium oxysporium and Aspergillus niger are described.     

Potentiometric studies on homo and hetero chelates of copper(II) with some hydroxy acids

Summary Ternary complex-forming systems of the type Cu(A)L (A = 2,2-dipyridyl and L = 2,4-dihydroxybenzoic acid,o-cresotic acid and 2-hydroxy-3-naphthoic acid) have been examined potentiometrically in 50% v/v aqueous ethanol. Various stability constants have been measured.     

DNA-binding and cleavage activity of polypyridyl ruthenium(II) complexes

Polypyridyl ruthenium(II) complexes [Ru^II(3-bptpy)(dmphen)Cl]ClO₄ (1), [Ru^II(3-cptpy)(dmphen)Cl]ClO₄ (2), [Ru^II(2-tptpy)(dmphen)Cl]ClO₄ (3), and [Ru^II(9-atpy)(dmphen)Cl]ClO₄ (4) {where 3-bptpy?=?4′-(3-bromophenyl)-2,2′:6′,2″-terpyridine, 3-cptpy?=?4′-(3-chlorophenyl)-2,2′:6′,2″-terpyridine, 2-tptpy?=?4′-(2-thiophenyl)-2,2′:6′,2″-terpyridine, 9-atpy?=?4′-(9-anthryl)-2,2′:6′,2″-terpyridine, dmphen?=?2,9-dimethyl-1,10-phenanthroline} have been synthesized and characterized. The DNA-binding properties of the complexes with Herring Sperm DNA have been investigated by absorption titration and viscosity measurements. The ability of complexes to break the pUC19 DNA has been checked by gel electrophoresis. The experimental results suggest that all the complexes bind DNA via partial intercalation. The results also show that the order of DNA-binding affinities of the complexes is 4?<?3?<?2?<?1, confirming that planarity of the ligand in a complex is very important for DNA-binding.     

Synthesis and magnetic studies of phthalato-bridged oxovanadium(IV) binuclear complexes

Six new μ-phthalato binuclear oxovanadium(IV) complexes, namely [(VO)₂(PHTH)-(L)₂]SO₄ (L denotes 2,2′-bipyridine (bpy); 1,10-phenanthroline (phen); 4,4′-dimethyl-2,2′-bipyridine (Me₂ bpy); 5-nitro-1,10-phenanthroline (NO₂-phen); 5-chloro-1,10-phenanthroline (Cl-phen) and 5-methyl-1,10-phenanthroline (CH₃-phen), where PHTH is the phthalate dianion), have been synthesized and characterized by elemental analyses, IR, electronic spectra, magnetic moments at room temperature and molar conductivity measurements. The temperature dependence of the magnetic susceptibility of complexes [(VO)₂(PHTH)(phen)₂]SO₄ (1) and [(VO)₂(PHTH)(CH₃-phen)₂]SO₄ (2) was measured in 4—300 K range and the observed data were successfully simulated by the equation based on the spin Hamiltonian operator, ?=?2J?₁·?₂, giving the exchange integrals J=?12.8 cm^?1 for 1 and J=?7.9 cm^?l for 2. This indicates an antiferromagnetic spin-exchange interaction between the metal ions within each molecule.     

Synthesis,characterization and crystal structure of ruthenium(II) polypyridyl complexes

[Ru(bipy)2(5-R-phen)](ClO4)2 complexes have been prepared, where bipy=2,2- bipyridine, phen=1,10-phenanthroline, and R=H, Me, NO2 or NH2. The influence of the different 5- substituted phen on the electron delocalization and ligand-ligand interactions have been investigated by solution n.m.r.. The ligand- ligand interaction has also been observed in the solid state by determining the single crystal structure of [Ru(bipy)2(5- NO2-phen)](ClO4)2. The strong steric interaction between the polypyridyl ligands was relieved neither by the elongation of Ru–N bonds (2.055–2.086Å) nor by increase of N–Ru–N bite angles (77.8–79.4°), but rather by distortion of the coordination sphere by forming specific angles (=2.0, 3.2 and 4.2°) between the polypyridyl ligand planes and coordination planes (N–Ru–N), and larger torsion angles (5.8 and 8.2°) between the two pyridine rings for each bipy.     

Synthesis,spectral, and catalytic studies of ruthenium(II) unsymmetrical Schiff-base complexes

Unsymmetrically-substituted ruthenium(II) Schiff-base complexes, [Ru(CO)(B)(L ^x )] [B = PPh₃, AsPh₃ or Py; L ^x = dianion of tetradentate unsymmetrical Schiff-base ligand; x = 4–7, L⁴ = salen-o-hyac, L⁵ = valen-o-hyac, L⁶ = salphen-o-hyac, L⁷ = valen-2-hacn], were prepared and characterized by analytical, IR, electronic, and ¹H NMR spectral studies. The new complexes were tested for their catalytic activity towards the oxidation of benzylalcohol to benzaldehyde.     

Synthesis and characterisation of new pyrazole-phosphinite ligands and their ruthenium(II) arene complexes

The new potentially bidentate pyrazole-phosphinite ligands [(3,5-dimethyl-1H-pyrazol-1-yl)methyl diphenylphosphinite] (L¹) and [2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl diphenylphosphinite] (L²) were synthesised and characterised. The reaction of L¹ and L² with the dimeric complexes [Ru(η⁶-arene)Cl₂]₂ (arene = p-cymene, benzene) led to the formation of neutral complexes [Ru(η⁶-arene)Cl₂(L)] (L = L¹, L²) where the pyrazole-phosphinite ligand is κ¹-P coordinated to the metal. The subsequent reaction of these complexes with NaBPh₄ or NaBF₄ produced the [Ru(η⁶-p-cymene)Cl(L²)][BPh₄] and [Ru(η⁶-benzene)Cl(L²)][BF₄] compounds which contain the pyrazole-phosphinite ligand κ²-P,N bonded to ruthenium. All the complexes were fully characterised by analytical and spectroscopic methods. The structure of the complex [Ru(η⁶-p-cymene)Cl(L²)][BPh₄] was also determined by a X-ray single crystal diffraction study.     

Synthesis, characterization and magnetism of binuclear cobalt (II) complexes bridged by tetracarboxylato groups

Three new binudear cobalt (II) complexes with extended te-tracarboxylato- bridge have been synthesized and characterized, namely [Co2 (PMTA) (bpy)4] (1), [Co2(PMTA)-(phen)4] (2) and [Co2(PMTA) (NO2phen)4] (3), where PMTA represents the tetraanion of pyroniellitic acid, and bpy, phen, NO2-phen denote 2,2'-bipyridine, 1,10-phenan-throline; 5-nirto-1, 10-plienanthroline, respectively. Based on elemental analyses, molar conductivity measurements, IR and electronic spectra studies, it is proposed that these complexes have PMTA-bridged structures and consist of two cobalt (II) ions, each in a distorted octahedral environment. These complexes were further characterized by variable temperature magnetic susceptibility measurements (4-300 K) and the observed data were successfully simulated by the equation based on the spin Hamiltonian operator, giving the exchange integral J = - 1.02 cm-1 for 1, J = -1.21 cm-1 for 2 and J = - 1.18 cm-1 for 3, respectively. These results revealed the operation of antiferromagneti     

Synthesis,characterization and in vitro biological activities of ruthenium(II) polypyridyl complexes

The ruthenium(II) polypyridyl complexes [Ru(dmb)₂(TCPI)](PF₆)₂ (1) and [Ru(ttbpy)₂(TCPI)](PF₆)₂ (2) (dmb = 4,4′-dimethyl-2,2′-bipyridine, TCPI = 2-(3-(1H-1,3,7,8-tetraazacyclopenta[l]phenanthren-2-yl)phenyl)benzo[de]isoquinoline-1,3-dione, ttbpy = 4,4′-ditertiary butyl-2,2′-bipyridine) were synthesized and characterized. The in vitro cytotoxicities of the complexes were examined against a panel of cancer cell lines including SGC-7901, PC-12, HepG-2, SiHa, Eca-109, HeLa, Eca-9706, HOS and LO₂ by 3-(4,5-dimethylthiazole)-2,5-diphenyltetrazolium bromide (MTT) method. Both complexes show higher activities against PC-12 cells, with IC₅₀ values of 34.4 ± 1.3 and 26.8 ± 2.4 μM for 1 and 2, respectively. Cell apoptosis was assayed with acridine orange (AO) and ethidium bromide (EB) and annexin V/PI staining methods using fluorescence microscopy and flow cytometry. The reactive oxygen species, mitochondrial membrane potential and cell cycle distribution were assessed. Cell invasion was determined by Matrigel invasion assay, and the proteins associated with cell apoptosis were analyzed by western blot. The results suggest that the complexes induce the apoptosis of PC-12 cells through a ROS-mediated mitochondrial dysfunction pathway, accompanied by regulation of the expression of caspases and Bcl-2 family proteins.     

Synthetic,spectral, structural and antimicrobial studies of some Schiff bases 3-d metal complexes

The complexes of tailor made ligands with life essential metal ions may be an emerging area to answer the problems of multi-drug resistance (MDR). The coordination complexes of VO(II), Co(II), Ni(II) and Cu(II) with the Schiff bases derived from 3-bromobenzaldehyde/3-chlorobenzaldehyde with 2-aminophenol have been synthesized and characterized by elemental analysis, molar conductance, electronic spectra, FT-IR, ESR, FAB mass, thermal and magnetic susceptibility measurements, FAB mass and thermal data show degradation of complexes. Both the ligands behave as bidentate coordinating through O and N donor. The complexes exhibit coordination number 4, 5 or 6. X-ray powder diffraction data shows that four (2, 3, 6 and 7) complexes are crystallized in tetragonal system. The in vitro biological screening effects of the investigated compounds were tested against the bacteria Escherichia coli, Staphylococcus aureus and Streptococcus fecalis and the fungi Aspergillus niger, Trichoderma polysporum and Candida albicans by serial dilution method. A comparative study of the MIC values of the Schiff base and their Co(II) (6) and Cu(II) (8) complexes, indicates that the metal complexes exhibit higher or lower antimicrobial activity than the free ligand (L₂).     

Synthesis,structural, electrochemical,and spectroscopic studies of some (diimine)ruthenium nitrile complexes

The syntheses of cationic ruthenium(II) complexes [Ru(Me₂-bpy)(PPh₃)₂RR?][PF₆]_x {Me₂-bpy = 4,4?-dimethyl-2,2?-bipyridine, (3) R = Cl, R? = N≡CMe, x = 1, (4) R = Cl, R? = N≡CPh, x = 1, (5) R = R? = N≡CMe, x = 2} and [Ru(Me₂-bpy)(κ²-dppf)RR?][PF₆]_x {dppf = 1,1?-bis(diphenylphosphino)ferrocene, (6) R = Cl, R? = N≡CMe, x = 1, (7) R = Cl, R? = N≡CPh, x = 1, (8) R = R? = N≡CMe, x = 2} are reported, together with their structural confirmation by NMR (³¹P, ¹H) and IR spectroscopy and elemental analysis, and, in the case of trans-[Ru(Me₂-bpy)(PPh₃)₂(N≡CCH₃)Cl][PF₆] (3), by X-ray crystallography. Electronic absorption and emission spectra of the complexes reveal that all complexes except 4 and 6 are emissive in the range 370–400 nm with 8 exhibiting an emission in the blue. Cyclic voltammetry studies of 3–8 show reversible or quasi-reversible redox processes at ca. 1 V, assigned to the Ru(II/III) couple.     

Synthesis,characterization, and cytotoxic and antimicrobial activities of ruthenium(II) arene complexes with N,N-bidentate ligands

Three new complexes, [(η⁶-C₆H₆)RuCl(C₅H₄N-2-CH=N-Ar)]PF₆ (Ar = phenylmethylene (1), (4-methoxyphenyl)methylene (2), and phenylhydrazone (3)), were prepared by reacting [(η⁶-C₆H₆)Ru(μ-Cl)Cl]₂ with N,N′-bidentate ligands in a 1 : 2 ratio. Full characterization of the complexes was accomplished using ¹H and ¹³C NMR, elemental and thermal analyses, UV–vis and IR spectroscopy and single crystal X-ray structures. Single crystal structures confirmed a pseudo-octahedral three-legged, piano-stool geometry around Ru(II), with the ligand coordinated to the ruthenium(II) through two N atoms. The cytotoxicity of the mononuclear complexes was established against three human cancer cell lines and selectivity was also tested against non-cancerous human epithelial kidney (HEK 293) cells. The compounds were selective toward the tumor cells in contrast to the known anti-cancer drug 5-fluoro uracil which was not selective between the tumor cells and non-tumor cells. All the compounds showed moderate activity against MCF7 (human breast adenocarcinoma), but showed low antiproliferative activity against Caco-2 and HepG2. Also, antimicrobial activities of the complexes were tested against a panel of antimicrobial-susceptible and -resistant Gram-negative and Gram-positive bacteria. Of special interest is the anti-mycobacterial activity of all three synthesized complexes against Mycobacterium smegmatis, and bactericidal activity against resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus ATCC 43300.     

Pentamethylcyclopentadienyl ruthenium(II) complexes of para-substituted N-(pyrid-2-ylmethylene)-phenylamine ligands: syntheses,spectral and structural studies

The reaction of [(η⁵-C₅Me₅)Ru(PPh₃)₂Cl] (1) with acetonitrile in the presence of excess NH₄PF₆ leads to the formation of the cationic ruthenium(II) complex [(η⁵-C₅Me₅)Ru(PPh₃)₂(CH₃CN)]PF₆ (2). The complex (2) reacts with a series of N,N′ donor Schiff base ligands viz. para-substituted N-(pyrid-2-ylmethylene)-phenylamines (ppa) in methanol to yield pentamethylcylopentadienyl ruthenium(II) Schiff base complexes of the formulation [(η⁵-C₅Me₅)Ru(PPh₃)(C₅H₄N-2-CHN-C₆H₄-p-X)]PF₆ [3a]PF₆–[3f]PF₆, where C₅Me₅ = pentamethylcylopentadienyl, X = H, [3a]PF₆, Me, [3b]PF₆, OMe, [3c]PF₆, NO₂, [3d]PF₆, Cl, [3e]PF₆, COOH, [3f]PF₆. The complexes were isolated as their hexafluorophosphate salts. The complexes were fully characterized on the basis of elemental analyses and NMR spectroscopy. The molecular structure of a representative complex, [(η⁵-C₅Me₅)Ru(PPh₃)(C₅H₄N-2-CHN-C₆H₄-p-Cl)]PF₆ [3e]PF₆, has been established by X-ray crystallography.